Results 131 to 140 of about 85,174 (277)

Work Versus Force: Simultaneous Processes for Describing Interactions

open access: yesAdvanced Physics Research, Volume 5, Issue 6, June 2026.
ABSTRACT Achieving a unified description of interactions remains an open challenge in theoretical physics, which currently describes four fundamental forces. This situation may be viewed differently when interactions are formulated in terms of processes (work as actio) rather than forces (force as actio), not only at the macroscopic level but also at ...
Grit Kalies   +2 more
wiley   +1 more source

High prevalence of KPC-2-producing hypervirulent Klebsiella pneumoniae causing meningitis in Eastern China

open access: yes, 2019
Min Xu,1,* Yiqi Fu,2,* Yunhui Fang,3 Hao Xu,3 Haishen Kong,3 Yanchao Liu,1 Yu Chen,1,3 Lanjuan Li3 1Key Laboratory of Clinical In Vitro Diagnostic Techniques of Zhejiang Province, Center of Clinical Laboratory, The First Affiliated Hospital, College of ...
Fang Y   +7 more
core  

Kinetic parameters of KPC variants.

open access: yes, 2015
Kinetic parameters of KPC variants.
Timothy Palzkill (47788)   +2 more
core   +1 more source

Treatment Adherence Pattern among HIV/AIDS Patients Receiving Treatment in the ART Centre of a Tertiary Hospital in Kolkata

open access: yesNational Journal of Community Medicine, 2016
Background: WHO recommended at least 95% adherence to antiretroviral drugs for better outcome in terms of improved CD4 count, body weight, general well-being and decreased chance of drug resistance.
Atanu Biswas, Asok Kumar Mandal
doaj  

Relebactam is a potent inhibitor of the kpc-2 -lactamase and restores imipenem susceptibility in kpc-producing enterobacteriaceae

open access: yes, 2018
The imipenem-relebactam combination is in development as a potential treatment regimen for infections caused by Enterobacteriaceae possessing complex -lactamase backgrounds. Relebactam is a -lactamase inhibitor that possesses the diazabicyclooctane core,
Alsop J.   +9 more
core   +1 more source

Genomic characterization of a KPC-23-producing Klebsiella pneumoniae ST258 clinical isolate resistant to ceftazidime-avibactam.

open access: yesClinical Microbiology and Infection, 2019
OBJECTIVES We characterized the first ceftazidime-avibactam-resistant KPC-producing-Klebsiella pneumoniae clinical isolate detected in Greece, before the introduction of ceftazidime-avibactam in clinical practice. METHODS K.
I. Galani   +5 more
semanticscholar   +1 more source

Arp2/3 complex and β1 integrin drive an invasive front through extracellular matrix adaptation in pancreatic cancer

open access: yesInternational Journal of Cancer, Volume 158, Issue 11, Page 3038-3050, 1 June 2026.
What's new? Pancreatic ductal adenocarcinoma is characterized by a dense extracellular matrix, and how invasive tumor cells overcome such biomechanical constraints remains unclear. This study identifies the actin‐related protein 2/3 complex as a key regulator of pancreatic ductal adenocarcinoma invasiveness, driving fibroblast migration through β1 ...
Xiufen Yang   +15 more
wiley   +1 more source

Modifikasi Modem Kantronics KPC-3 untuk Apikasi pada Sistem APRS /Minto Suwarjo; Rakhmad Yatim; Irwan Priyanto

open access: yes, 2010
Abstrak Modem KPC-3+ pada umumnya dipergunakan untuk mendukungsistem komunikasi paket data. Pada modem ini dilakukan modifikasi kanal input analog untuk masukan sensor dan pemanfaatan sakelar untuk mengaktifkan sistem kamera disamping untuk mengaktifkan ...
Minto Suwarjo   +2 more
core  

First report of KPC variants conferring ceftazidime-avibactam resistance in Colombia: introducing KPC-197

open access: yesMicrobiology Spectrum
ABSTRACT Resistance to ceftazidime-avibactam (CZA) due to Klebsiella pneumoniae carbapenemase (KPC) variants is increasing worldwide. We characterized two CZA-resistant clinical Klebsiella pneumoniae strains by antimicrobial susceptibility test ...
Elsa De la Cadena   +11 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy